Strongyloides

Strongyloides infection, also known as strongyloidiasis, is a parasitic disease caused by the threadworm Strongyloides stercoralis in dogs. These tiny, hair-like nematodes are unique among intestinal parasites due to their ability to complete their entire life cycle within a single host through a process called autoinfection, potentially leading to persistent, self-perpetuating infections that can become increasingly severe over time. While Strongyloides infection is less commonly diagnosed than roundworms or hookworms in dogs, it remains an important parasitic disease, particularly in kennels, breeding facilities, and regions with warm, humid climates where environmental conditions favor parasite survival and transmission.

The life cycle of Strongyloides stercoralis is remarkably complex and distinguishes this parasite from other common canine intestinal worms. The adult parasitic females live embedded in the mucosa of the small intestine, where they produce eggs by parthenogenesis without requiring fertilization by males. These eggs hatch rapidly, and the resulting larvae pass out in the feces. Under favorable environmental conditions, larvae can develop into infective forms capable of penetrating the skin or being ingested to infect new hosts. Alternatively, larvae can complete development to free-living adult males and females in the soil, producing additional generations that eventually yield infective larvae. Most significantly, larvae can also develop to the infective stage while still within the host's intestine, allowing them to reinfect the same animal and perpetuate the infection indefinitely.

The impact of Strongyloides infection on canine health varies considerably depending on the intensity of infection and the immune status of the host. In healthy adult dogs with functioning immune systems, infections are often subclinical or cause only mild, intermittent digestive symptoms. However, in puppies, immunocompromised dogs, or dogs experiencing autoinfection cycles, the disease can become severe and even life-threatening. Heavy infections cause significant damage to the intestinal lining, resulting in malabsorption, protein loss, and diarrhea. The larval migration phase, during which infective larvae travel through the lungs before reaching the intestine, can cause respiratory symptoms including coughing and, in severe cases, pneumonia.

Treatment of Strongyloides infection requires carefully selected anthelmintic medications, as not all dewormers commonly used for other intestinal parasites are equally effective against this parasite. The potential for autoinfection means that treatment must be thorough to prevent persistence of the infection, and repeated courses or prolonged treatment may be necessary. Environmental decontamination is particularly important given the parasite's ability to develop in soil and the potential for continuous reexposure in contaminated environments. The zoonotic potential of Strongyloides stercoralis, with documented transmission between dogs and humans, adds a public health dimension to the importance of diagnosis and treatment. Veterinary guidance is essential for appropriate diagnosis and management of this sometimes challenging parasitic infection.

The primary cause of strongyloidiasis in dogs is infection with the parasitic nematode Strongyloides stercoralis, though Strongyloides tumefaciens has also been reported in canine infections in certain regions. Dogs acquire infection primarily through two routes: percutaneous penetration, where infective larvae in contaminated soil or bedding penetrate directly through the skin, and oral ingestion of infective larvae. The skin penetration route is particularly important for this parasite, with larvae typically entering through the thin skin of the paws, abdomen, or other areas in contact with contaminated surfaces. Transmammary transmission from mother to nursing puppies also occurs, making this a significant source of infection in young dogs from endemic environments.

While genetic factors do not determine susceptibility to Strongyloides infection, the parasite's unique ability to cause autoinfection creates circumstances where host factors significantly influence disease severity. In autoinfection, larvae develop to the infective stage while still within the host's gastrointestinal tract, penetrate the intestinal wall or perianal skin, and migrate through the body to establish new adult infections. This process allows a single initial infection to amplify over time, particularly in immunocompromised hosts where the immune system cannot control the parasite population. Dogs receiving immunosuppressive medications, those with concurrent immunosuppressive diseases, or those experiencing chronic stress are at risk for hyperinfection syndrome where parasite numbers multiply dramatically.

Environmental and lifestyle factors play crucial roles in Strongyloides transmission and disease expression. The parasite thrives in warm, humid environments where contaminated soil remains moist, making infections more common in tropical and subtropical regions and during warm, wet seasons in temperate areas. Kennel environments present particular risk due to the combination of high dog density, potential for widespread environmental contamination, and warm, moist conditions often found in kennel floors and runs. Dogs housed on dirt or gravel surfaces, in facilities with poor drainage, or in areas where fecal material is not promptly removed face increased exposure risk. Poor hygiene practices and inadequate sanitation facilitate environmental accumulation of infective larvae.

Multiple risk factors increase the likelihood of Strongyloides infection and the potential for severe disease. Age is a significant factor, with young puppies being particularly vulnerable to severe infection acquired through transmammary transmission or early environmental exposure. Dogs in crowded housing situations such as kennels, breeding facilities, and shelters face higher exposure rates. Immunocompromised status dramatically increases the risk of severe disease, as the immune system normally plays a crucial role in controlling parasite numbers and preventing autoinfection cycles. Dogs receiving corticosteroids, chemotherapy, or other immunosuppressive treatments are at particular risk. Poor nutrition weakens immune function and can allow more severe infection development.

Understanding the mechanism of Strongyloides infection reveals why this parasite can cause such persistent and potentially severe disease. When infective larvae enter the body through skin penetration, they travel through the bloodstream to the lungs, migrate up the airways, and are swallowed to reach the small intestine where they mature into parasitic adult females. These females embed themselves in the intestinal mucosa and begin producing eggs that rapidly hatch into larvae. In most cases, these larvae are passed out in the feces. However, some larvae can accelerate their development and become infective while still within the intestine or immediately after passing in the feces, penetrating the perianal skin or intestinal wall to begin the migration cycle again. This autoinfection cycle can continue indefinitely, and in immunocompromised hosts, can lead to overwhelming parasite burdens affecting multiple organ systems.

Early warning signs of Strongyloides infection are often subtle and may be dismissed as minor digestive upset or other common puppy ailments. Initial symptoms typically include mild, intermittent diarrhea that may come and go over days or weeks. Some dogs develop slightly loose or soft stools without obvious diarrhea. Mild skin irritation, particularly between the toes or on the abdomen where larvae may have penetrated, sometimes presents as the first sign but is often overlooked or attributed to environmental irritants. Young puppies may show slightly decreased growth rates compared to uninfected littermates. Occasional coughing during the early larval migration phase may occur but is usually mild and transient.

The most common symptoms of established Strongyloides infection center on gastrointestinal disturbance and failure to thrive. Diarrhea is the hallmark symptom, typically characterized by watery, mucoid, or bloody stool that may be persistent or intermittent. The stool often has a particularly foul odor and may contain visible mucus. Abdominal discomfort manifests as restlessness, a hunched posture, or reluctance to be touched around the belly. Weight loss or failure to gain weight appropriately occurs due to both malabsorption from intestinal damage and nutrient competition from the parasites. In puppies, a pot-bellied appearance similar to that seen with other intestinal parasites may develop.

Behavioral changes associated with Strongyloides infection reflect the chronic discomfort and debilitation caused by the disease. Infected dogs often become increasingly lethargic, with decreased interest in play and normal activities. Appetite changes are common, ranging from decreased food intake to complete anorexia in severely affected dogs. Some dogs become irritable or show personality changes related to chronic discomfort. Young puppies may fail to engage with littermates and show reduced activity levels. Dogs with chronic infection may appear depressed and withdrawn. Sleep patterns may be disrupted by gastrointestinal discomfort, and dogs may change positions frequently trying to find relief.

Physical signs of Strongyloides infection extend beyond gastrointestinal symptoms. Skin lesions may appear at sites of larval penetration, typically presenting as small, red, irritated patches that may be itchy or develop into small pustules. A condition called larva currens can occur when larvae migrate just beneath the skin surface, creating characteristic serpiginous, raised, reddened tracks that move across the skin over hours, though this is more commonly described in human infections. Weight loss becomes pronounced in chronic infections, with visible loss of muscle mass and poor body condition. The coat may become dull, dry, and unkempt. Dehydration may develop in dogs with persistent diarrhea.

Symptom progression in Strongyloides infection depends heavily on the immune status of the host and whether autoinfection is occurring. In immunocompetent adult dogs, infections may remain stable at low levels with minimal or intermittent symptoms for extended periods. However, in puppies, immunocompromised dogs, or those with active autoinfection cycles, the disease can progress from mild symptoms to severe illness over weeks to months. Diarrhea becomes more persistent and severe, and bloody diarrhea may develop as intestinal damage worsens. Weight loss accelerates as malabsorption increases. Respiratory symptoms may become more prominent as increasing numbers of larvae migrate through the lungs.

Emergency symptoms requiring immediate veterinary attention reflect the potential for severe, life-threatening disease with Strongyloides hyperinfection. Severe, uncontrolled diarrhea leading to rapid dehydration and electrolyte imbalances constitutes a medical emergency, particularly in puppies. Signs of severe dehydration including extreme lethargy, collapse, dry mucous membranes, and loss of skin elasticity demand urgent care. Significant respiratory distress with labored breathing, persistent coughing, or cyanosis may indicate severe pulmonary involvement. Bloody diarrhea with large amounts of fresh blood suggests severe intestinal damage. Any signs of shock including cold extremities, rapid weak pulse, or collapse require emergency intervention. In immunocompromised dogs, disseminated strongyloidiasis affecting multiple organ systems can develop rapidly and is a life-threatening emergency.

The diagnostic process for Strongyloides infection begins with clinical evaluation and a thorough history taking by the veterinarian. During physical examination, the veterinarian assesses overall body condition, hydration status, and looks for signs of illness such as lethargy or abdominal discomfort. The skin is examined for any lesions suggestive of larval penetration, particularly between the toes, on the ventral abdomen, and around the perianal area. A detailed history including the dog's housing conditions, exposure to kennel environments, geographic travel history, immunosuppressive treatments or conditions, and duration and character of symptoms helps establish the likelihood of Strongyloides infection and guides diagnostic testing.

Diagnosis of Strongyloides infection presents unique challenges because standard fecal flotation techniques may miss this parasite. Unlike most intestinal parasites that pass eggs in the feces, Strongyloides eggs hatch rapidly, and it is larvae rather than eggs that are found in fresh fecal samples. The Baermann technique, a specialized procedure that uses the larvae's attraction to warmth and moisture to concentrate them from fecal material, is the most reliable method for detecting Strongyloides larvae. Direct fecal smears of fresh samples may also reveal motile larvae. Because larval output can be intermittent, multiple samples collected over several days increase diagnostic sensitivity. In suspected cases with negative initial tests, empirical treatment may be warranted, with response to therapy confirming the diagnosis.

Differential diagnosis considers other conditions that produce similar symptoms. Other intestinal parasites including hookworms, roundworms, whipworms, and Giardia cause gastrointestinal symptoms and should be investigated through comprehensive fecal testing. Bacterial enteritis from organisms such as Campylobacter or Clostridium produces diarrhea similar to parasitic infection. Parvovirus in puppies causes severe diarrhea and must be ruled out, particularly in young, unvaccinated dogs. Inflammatory bowel disease creates chronic gastrointestinal symptoms. Food intolerance or allergy may cause persistent diarrhea. In immunocompromised dogs with respiratory symptoms, the differential diagnosis expands to include various pulmonary infections and other causes of pneumonia.

Once Strongyloides infection is diagnosed or strongly suspected, the veterinarian assesses the severity of infection and the host's immune status to guide treatment planning. The intensity of larval output in fecal samples provides some indication of infection severity. Complete blood counts may reveal eosinophilia, though this finding is not consistent. Assessment of immune status, including any underlying conditions or medications that might promote autoinfection or hyperinfection, is crucial for predicting disease course and treatment response. Any concurrent respiratory symptoms may warrant chest radiographs to evaluate pulmonary involvement. Response to initial treatment serves as an important indicator for prognosis and guides decisions about treatment duration and follow-up testing schedules.

Initial treatment for Strongyloides infection focuses on eliminating the parasite while providing appropriate supportive care for any associated symptoms. For dogs with uncomplicated infections, outpatient treatment with appropriate anthelmintic medications and supportive care is usually sufficient. Dogs with severe symptoms, significant dehydration, or signs of hyperinfection syndrome may require hospitalization for fluid therapy, nutritional support, and intensive monitoring. In cases with respiratory involvement, oxygen supplementation and management of secondary bacterial pneumonia may be necessary. Immunocompromised dogs require careful management, and any immunosuppressive medications should be reduced or discontinued if medically possible.

The pharmacological treatment of Strongyloides infection requires specific medication selection, as not all commonly used dewormers are equally effective against this parasite. Ivermectin is generally considered the most effective treatment for canine strongyloidiasis when used at appropriate doses for the required duration. Fenbendazole at higher doses and for longer treatment courses than typically used for other parasites may also be effective. Treatment often needs to be continued for multiple consecutive days rather than as a single dose, and the course may need to be repeated to ensure complete elimination given the potential for autoinfection. In dogs with hyperinfection syndrome, more prolonged and intensive treatment regimens are necessary. Breed-related sensitivities to ivermectin in collie-type breeds must be considered when selecting treatment.

Surgical intervention is not applicable for Strongyloides treatment, as the infection is managed entirely through medical therapy. However, severe complications of the infection may occasionally require interventional management. In extremely rare cases where overwhelming intestinal involvement leads to perforation or peritonitis, surgical intervention might be necessary, though this would be an exceptional circumstance. The primary management of Strongyloides infection, including severe and disseminated cases, relies on appropriate antiparasitic treatment combined with supportive care measures.

Supportive care is an essential component of Strongyloides treatment, particularly for dogs with significant symptoms or heavy infections. Fluid therapy addresses dehydration from diarrhea and supports overall physiological function. Nutritional support helps counteract the malnutrition and weight loss associated with chronic infection, with highly digestible diets often recommended during recovery. Probiotic supplementation may help restore healthy intestinal flora disturbed by both the infection and treatment. Dogs with significant protein loss may benefit from dietary protein supplementation. Symptomatic treatment of diarrhea with appropriate medications may be used adjunctively, though eliminating the parasite remains the primary goal.

Complementary approaches focus heavily on environmental management and prevention of reinfection, which are particularly crucial for Strongyloides given the parasite's ability to perpetuate in contaminated environments. Thorough cleaning and disinfection of kennel surfaces, bedding, and all areas where the infected dog has been housed help eliminate environmental contamination. Because the larvae can develop quickly in warm, moist conditions, keeping environments clean and dry reduces transmission risk. Prompt removal of all fecal material prevents larval development and accumulation. Steam cleaning or hot water treatment of surfaces provides more effective decontamination than chemical disinfectants alone for this parasite. Infected dogs should be isolated from other susceptible animals during treatment.

Treatment decisions are influenced by several factors including the severity of infection, immune status of the patient, and environmental circumstances. For immunocompetent dogs with mild infections, standard treatment courses are usually successful. Immunocompromised dogs require more aggressive and prolonged treatment regimens and may need ongoing suppressive therapy if their immunosuppressive condition cannot be resolved. Multi-dog environments such as kennels require simultaneous treatment of all dogs combined with intensive environmental decontamination to eliminate the infection from the facility. Cost considerations may influence treatment choices, though the potential for autoinfection makes thorough treatment particularly important to prevent chronic, recurring disease. With appropriate treatment and environmental management, prognosis for Strongyloides infection is generally good in immunocompetent dogs.

Recovery from Strongyloides infection typically progresses well once appropriate treatment is initiated and the autoinfection cycle is interrupted. Dogs with uncomplicated infections often show improvement in gastrointestinal symptoms within days of starting effective anthelmintic treatment, with decreased diarrhea and improved stool consistency among the early signs of response. Appetite usually improves within the first week of treatment as intestinal inflammation begins to resolve. Energy levels increase progressively as the parasitic burden decreases and nutritional absorption normalizes. Complete resolution of symptoms typically occurs within two to four weeks of treatment initiation, though the timeline may be longer for dogs with severe or chronic infections.

Post-treatment care focuses on completing the full prescribed treatment course, confirming parasite elimination, and preventing reinfection. Treatment schedules for Strongyloides typically extend longer than for many other intestinal parasites to address the potential for autoinfection, and completing the full course is essential even if symptoms resolve quickly. Follow-up fecal testing using appropriate techniques for Strongyloides detection should be performed two to four weeks after completing treatment to confirm elimination. Environmental decontamination efforts should continue throughout recovery to prevent immediate reexposure. A gradual transition back to normal diet over one to two weeks helps ensure the recovering intestinal tract can handle regular food.

Prognosis for Strongyloides infection varies depending on host factors and infection severity. Immunocompetent adult dogs with uncomplicated infections have an excellent prognosis with appropriate treatment, typically achieving complete cure with no long-term effects. Puppies generally respond well to treatment but may require additional nutritional support to recover from growth deficits. Immunocompromised dogs have a more guarded prognosis, as the underlying condition may predispose to treatment failure, recurrence, or hyperinfection syndrome. Dogs with hyperinfection syndrome or disseminated disease have a guarded to poor prognosis, particularly if the underlying immunosuppressive condition cannot be corrected. Early treatment before severe disease develops significantly improves outcomes.

The long-term outlook for dogs successfully treated for Strongyloides depends on preventing reinfection and managing any underlying conditions that increase susceptibility. Dogs that recover from infection in isolated circumstances with environmental decontamination typically remain free of disease. However, dogs in endemic areas or contaminated environments face ongoing exposure risk. Regular monitoring and preventive treatment may be warranted for dogs in high-risk situations. Dogs with chronic immunosuppressive conditions may require ongoing surveillance or prophylactic treatment to prevent recurrence. With appropriate management, most dogs can maintain freedom from Strongyloides infection long-term.

Primary prevention of Strongyloides infection centers on reducing exposure to infective larvae through environmental management and hygiene practices. Maintaining clean, dry living environments is fundamental, as larvae thrive in warm, moist conditions. Kennel surfaces should be constructed of materials that can be easily cleaned and dried, with concrete or other impermeable surfaces preferred over dirt or gravel. Excellent drainage prevents water accumulation that supports larval survival. Regular cleaning with hot water or steam treatment more effectively eliminates larvae than chemical disinfectants alone. Prompt removal of all fecal material before larvae can develop reduces environmental contamination. In endemic areas, preventing dogs from direct contact with potentially contaminated soil limits exposure.

Responsible breeding practices help prevent transmission from mothers to puppies. Pregnant dogs in known endemic environments or with suspected prior infection should be tested and treated before whelping. Maintaining breeding animals in clean, well-managed facilities reduces their exposure and infection risk. Whelping areas should be scrupulously clean and maintained in a dry condition. Nursing mothers should be monitored and treated if infection is detected. Puppies from endemic environments should receive early veterinary evaluation and appropriate treatment. Sourcing puppies from facilities with good parasite control practices reduces the likelihood of acquiring infected animals.

Nutritional factors support immune function and help dogs resist infection and control parasite numbers naturally. A complete and balanced diet providing all essential nutrients maintains optimal immune system function. Adequate protein intake supports immune responses against parasitic infections. Puppies benefit from high-quality nutrition during their developmental period when they are most vulnerable to parasitic disease. Maintaining healthy body condition supports overall resistance to infection. While good nutrition cannot prevent exposure, well-nourished dogs typically experience less severe disease if infected.

Regular veterinary care enables early detection and treatment of infections before they cause significant disease or environmental contamination. Fecal examinations should be part of routine preventive care, with specific testing for Strongyloides larvae if infection is suspected based on symptoms or exposure history. Dogs from shelter, kennel, or breeding facility backgrounds should be tested as part of initial veterinary evaluation. Discussion with the veterinarian about local Strongyloides prevalence and risk factors helps determine appropriate monitoring strategies. Dogs with immunosuppressive conditions or receiving immunosuppressive medications require heightened surveillance.

Early intervention when exposure is suspected or initial symptoms appear prevents progression to more severe disease. Dogs known to have been in contaminated environments should be monitored closely and tested promptly if symptoms develop. Immediate treatment of diagnosed infections prevents environmental contamination and protects other animals. In kennel or multi-dog situations where one dog is diagnosed, testing and potentially treating all exposed dogs helps eliminate the infection from the facility. Environmental decontamination should begin immediately upon diagnosis. Working collaboratively with veterinary staff to develop appropriate prevention and monitoring strategies based on individual risk factors provides the best protection against Strongyloides infection.

Daily management during Strongyloides treatment requires meticulous attention to hygiene, medication administration, and environmental control. Medications should be given exactly as prescribed, typically for consecutive days over a longer course than many other parasitic treatments require. Owners should monitor stool quality and report any lack of improvement or worsening symptoms to the veterinarian. All fecal material must be removed from the environment immediately and disposed of safely to prevent environmental contamination and larval development. Wearing gloves when handling feces and washing hands thoroughly afterward protects owners from potential zoonotic exposure. Bedding should be washed daily in hot water during the active treatment period.

Home environmental management is particularly critical for Strongyloides control due to the parasite's ability to persist and multiply in contaminated environments. Indoor living areas should be cleaned thoroughly and regularly, with particular attention to areas where the dog sleeps or rests. Hard flooring surfaces are easier to decontaminate than carpeting, and area rugs should be steam cleaned or professionally treated. Outdoor areas where the dog has defecated should be cleaned of all fecal material, and limiting access to these areas until natural die-off of environmental stages occurs helps prevent reinfection. In kennel situations, intensive environmental decontamination including hot water treatment of all surfaces is essential for eliminating the infection.

Maintaining quality of life during treatment involves balancing necessary restrictions with continued enrichment and positive experiences. Most dogs feel increasingly better as treatment progresses and can engage in normal activities as their condition allows. Activity levels should match the dog's energy and comfort, with rest encouraged when needed. Mental stimulation through puzzle toys, gentle training sessions, and calm interaction helps maintain psychological well-being during any recovery restrictions. Social isolation from other dogs may be necessary during the treatment period to prevent transmission, requiring creative alternatives for companionship and stimulation.

Ongoing monitoring ensures treatment success and enables early detection of any recurrence. Owners should continue observing stool quality after treatment completion, watching for any return of diarrhea or other symptoms that might indicate persistent infection. Follow-up fecal testing at intervals recommended by the veterinarian confirms treatment success. Any return of symptoms should prompt immediate veterinary evaluation and repeat testing. For dogs with underlying immunosuppressive conditions, long-term monitoring may be necessary given their increased susceptibility to recurrence or hyperinfection.

Caring for a dog with Strongyloides infection presents challenges related to the need for intensive environmental management and the zoonotic potential of the parasite. The combination of extended treatment courses, follow-up testing, and environmental decontamination efforts creates cumulative costs and time demands. Concerns about human transmission may cause anxiety, particularly in households with immunocompromised family members, though following appropriate hygiene practices largely eliminates this risk. Understanding that thorough treatment and environmental management can successfully eliminate the infection helps owners maintain perspective and commitment to the necessary steps. Working closely with veterinary staff provides support and guidance throughout the treatment and recovery process.

Strongyloides infection does not demonstrate breed predisposition and can affect dogs of any breed, size, or genetic background when exposure occurs. The primary risk factors are environmental rather than genetic, with dogs in contaminated kennel environments, warm humid climates, and those with immunocompromising conditions facing the highest infection rates regardless of breed. However, certain breed-related factors may influence disease severity or treatment selection. Dogs of breeds carrying the MDR1 gene mutation, including Collies, Shetland Sheepdogs, Australian Shepherds, and related breeds, require careful consideration when ivermectin-based treatments are selected, potentially necessitating alternative medication choices or genetic testing before treatment.

Certain breed categories may face higher exposure risk based on typical housing and lifestyle circumstances. Breeds commonly produced in high-volume breeding operations may have higher infection rates at the time of sale due to kennel conditions that favor parasite transmission. Sporting and working breeds that spend significant time in outdoor environments where contaminated soil may be present face ongoing exposure risk. Small and toy breed puppies may develop more severe disease from equivalent parasite burdens due to their small size. Breeds predisposed to immunosuppressive conditions or commonly used in situations requiring immunosuppressive medications may face elevated risk for severe disease.

Screening recommendations for Strongyloides are based on risk factors and exposure history rather than breed-specific guidelines. All dogs from kennel, shelter, or breeding facility backgrounds should be evaluated for parasitic infections including Strongyloides as part of initial veterinary assessment. Dogs presenting with chronic diarrhea unresponsive to treatment for other common parasites should be tested specifically for Strongyloides using appropriate techniques. Dogs receiving immunosuppressive therapy or those with immunocompromising conditions warrant monitoring for this and other parasitic infections. In endemic areas, routine screening during annual veterinary visits may be appropriate. Working with a veterinarian to determine appropriate testing based on individual circumstances provides the best approach to detecting this sometimes elusive parasite.

Several conditions commonly occur alongside Strongyloides infection in dogs, reflecting shared risk factors and similar environmental transmission patterns. Concurrent infection with other intestinal parasites is common, particularly in dogs from kennel environments or those with inadequate parasite prevention. Hookworms, which share the skin-penetrating mode of transmission, often occur alongside Strongyloides. Roundworms, whipworms, and protozoal parasites such as Giardia and coccidia may also be present. Bacterial intestinal infections can coexist with or follow parasitic infections due to disruption of normal gut flora and intestinal barrier function. Skin infections at larval penetration sites may develop as secondary complications.

Several conditions produce symptoms similar to Strongyloides infection, making comprehensive diagnostic evaluation important. Other intestinal parasites cause overlapping gastrointestinal symptoms of diarrhea, weight loss, and poor condition. Bacterial enteritis produces similar gastrointestinal signs. Inflammatory bowel disease causes chronic diarrhea and malabsorption that may mimic parasitic infection. Parvovirus in puppies causes severe diarrhea requiring urgent differentiation. Food allergy or intolerance produces chronic digestive symptoms. In dogs with respiratory symptoms, various causes of pneumonia and other pulmonary diseases must be considered alongside the possibility of larval migration from Strongyloides.

Complications of Strongyloides infection, particularly in severe or hyperinfection cases, extend beyond primary gastrointestinal symptoms. Secondary bacterial pneumonia may develop when pulmonary larval migration creates opportunity for bacterial infection in the lungs. Bacterial septicemia can occur in hyperinfection syndrome when larvae carry intestinal bacteria into the bloodstream during tissue migration. Severe protein-losing enteropathy leads to hypoproteinemia with potential edema and ascites. Malnutrition and failure to thrive occur with chronic heavy infections. In humans, disseminated strongyloidiasis in immunocompromised individuals is a serious, potentially fatal condition, emphasizing the importance of the zoonotic risk associated with canine infection. Thorough treatment and prevention protect both canine and human health.